Skip to content

EndoflipTM 300

by Covidien llc

510(k) K223705

EndoflipTM 300 is a medical device (FDA Class II; FDA product code FFX, System, Gastrointestinal Motility (Electrical)) made by Covidien llc, cleared under FDA 510(k) K223705 on 14 Apr 2023, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK223705 Date14 Apr 2023ClearedStatusActive

Official records

From the FDA record

Received by the FDA
12 Dec 2022
FDA decision
14 Apr 2023 (Substantially Equivalent)
FDA review time
123 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K223705 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
FFX
FDA applicant
Covidien, LLC
Device class
Class II
Regulation
21 CFR Part 876.1725
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code FFX (System, Gastrointestinal Motility (Electrical)).

Other devices from Covidien llc

See all devices from Covidien llc →